000 | 01998 a2200601 4500 | ||
---|---|---|---|
005 | 20250515125954.0 | ||
264 | 0 | _c20081023 | |
008 | 200810s 0 0 eng d | ||
022 | _a0008-543X | ||
024 | 7 |
_a10.1002/cncr.23688 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJaveri, Heta | |
245 | 0 | 0 |
_aInfluence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. _h[electronic resource] |
260 |
_bCancer _cSep 2008 |
||
300 |
_a1302-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEsophagectomy _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
650 | 0 | 4 | _aPreoperative Care |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aArora, Rohan | |
700 | 1 | _aCorrea, Arlene M | |
700 | 1 | _aHofstetter, Wayne L | |
700 | 1 | _aLee, Jeffrey H | |
700 | 1 | _aLiao, Zhongxing | |
700 | 1 | _aMcAleer, Mary F | |
700 | 1 | _aMaru, Dipen | |
700 | 1 | _aBhutani, Manoop S | |
700 | 1 | _aSwisher, Stephen G | |
700 | 1 | _aIzzo, Julie G | |
700 | 1 | _aAjani, Jaffer A | |
773 | 0 |
_tCancer _gvol. 113 _gno. 6 _gp. 1302-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.23688 _zAvailable from publisher's website |
999 |
_c18104527 _d18104527 |